A375 cells have been used as test organisms that also produce paracrine factors for prolonged culture of mesenchymal stromal cells (MSCs). Melanoma is the most lethal formal of skin cancer and is responsible for more than 75% of skin cancer-related deaths. The A375 cell line is relevant to melanoma studies, and it was originally obtained from a 54-year-old female. A375 cells are epithelial-like with adherent properties, hypotriploid, and have a modal number of 62 chromosomes. The cells produce large amounts of amelanotic melanomas in xenografts of NIH swiss mice treated with anti-thymocyte serum. A375 cells are suitable for transfection applications, especially those that deal with oncogenetic factors that are tied to melanomas. For the A375 transfection reagent, visit the Altogen Biosystems website.
A-431 (CRL-1555) cancer cell line was established by DJ Giard and SA Aaronson from the solid tumor of a female patient suffering from epidermoid carcinoma; in cancer research, A431 cell line is used in medical research to study oncology treatments of skin cancer and is commonly used as a transfection host cell line. A431 transfection reagent is manufactured by Altogen Biosystems and has been reported to have a 81% transfection efficacy for the delivery of small RNA molecules. This reagent is functionally tested in vitro and has been proven to facilitate the development of A431 stable cell lines. In addition, A-431 transfection reagents for epidermoid carcinoma cell line work in the presence of serum and it is used in both reverse and standard transfection protocols. Transfection Reagent for A431 Cells
Comments
Post a Comment